Enzon Pharmaceuticals Inc (NASDAQ: ENZN) Enzon Pharmaceuticals stock is seeing a bit of a decline today. However, investor sentiment doesn't seem to be matching what we're seeing in the market. At least, that's the case when you …
Enzon Pharmaceuticals, Inc.
One needs to compare the QoQ or YoY topline growth of ENZN stock with its peers like GNVC stock and HEB stock to see if the growth compares well with what can be expected for a company in that industry. Bottom line: Most …
There were 10 hedge funds in our database with ENZN holdings at the end of the previous quarter. To most stock holders, hedge funds are assumed to be slow, outdated investment vehicles of years past. While there are over 8000 funds …
Monkey
Enzon Pharmaceuticals (Nasdaq:ENZN) hit a new 52-week low Friday as it is currently trading at $7.19, below its previous 52-week low of $7.20 with 102,690 shares traded as of 3:25 p.m. ET. Average volume has been 366,100 shares over the …
See Statistics Help for definitions of terms used. 1 Data provided by Thomson Reuters. 2 Data provided by EDGAR Online. 3 Data derived from multiple sources or calculated by Yahoo Finance. 4 Data provided by Morningstar, Inc. 5 Shares …
Alpha One analyzed the various web articles published on Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN), and thereafter it gave company a daily sentiment score of 0.56. The entity designs algorithm based assessment to known stock
(Editors' Note: This article covers a micro-cap stock. Please be aware of the risks associated with ... Enzon Pharmaceuticals (NASDAQ:ENZN) used to be a research stage biotech firm, focusing on a technology known as …
Enzon Pharmaceuticals, Inc.
Dallas, Texas 03/25/2014 (FINANCIALSTRENDS) – Last week, a United States District Court denied Santaris Pharma’s 2nd bid to have the patent- infringement lawsuit that was filed against it by the Isis Pharmaceuticals to be thrown out. …
The model portfolio continued to trail the S & P 500 in March. Of note, my Enzon (Nasdaq: ENZN) position has lost all its gain. Even so, I continue to believe Enzon is trading below the combined value of its PEG-INTRON therepy, its CIMZIA …